* Begins Enrollment In First Phase 3 Clinical Trial With Otx
Tp (sustained release travoprost) for the treatment of glaucoma
and ocular hypertension
The post BRIEF-Ocular Therapeutix(Tm) starts enrollment in phase 3 clinical trial with OTX-TP appeared first on NASDAQ.